Daily Alpha · YouTube
· Premarket Alpha · by Buzzberg Research
Who was talking 47 videos · 12 channels
Duration relief
2 videos · 1h 40mTreasury buybacks can improve long-end liquidity in the near term, but repeated interviews treated them as tactical debt management rather than a fiscal solution.
Moderna reports positive late-stage trial for cancer vaccine
Moderna's personalized mRNA cancer vaccine showed success in a late-stage trial for melanoma, signaling potential commercial expansion beyond infectious diseases.
US Treasury bond buybacks viewed as tactical, not structural
The US Treasury's expanded buyback program for 10-30 year securities is seen as a tactical intervention to manage liquidity and yields rather than a fundamental solution to the $40 trillion debt burden.
Memory capital returns
1 video · 1h 34mSK Hynix's repurchase and free-cash-flow commitment create a tangible shareholder-return test for the Korean memory cycle.
SK Hynix share buyback signals confidence in AI rally
SK Hynix announced a $29 billion share buyback to stabilize its stock price, which had fallen nearly 50% from its June peak, while committing to return over 50% of free cash flow to shareholders.
Oncology validation
1 video · 1h 35mPositive late-stage melanoma data gave Moderna a credible growth pillar beyond infectious disease, with regulatory and reimbursement work still ahead.
Moderna reports positive late-stage trial for cancer vaccine
Moderna's personalized mRNA cancer vaccine showed success in a late-stage trial for melanoma, signaling potential commercial expansion beyond infectious diseases.
Chinese AI sector faces profitability challenges
Despite rapid technological progress, Chinese AI companies are struggling to achieve profitability due to heavy capital expenditure requirements and intense domestic competition.
FCBGA substrate shortage expected to persist
Increasing AI chip complexity and size are driving a sustained shortage of FCBGA substrates, with demand expected to outstrip supply through late next year.